Fibronostics Overview

  • Founded
  • 2015
  • Status
  • Private
  • Employees
  • 17
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $8M
Latest Deal Amount
  • Investors
  • 7

Fibronostics General Information


Developer of a non-invasive diagnostic testing system intended to provide algorithm-based health monitoring solutions. The company's system focuses on assessing liver disease existence/progression and chronic areas such as coronary heart disease, stroke, diabetes, and obstructive sleep apnea, thereby allowing doctors as well patients to detect any early signs in order to facilitate efficient monitoring of diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Diagnostic Equipment
Primary Office
  • 3452 Lake Lynda Drive
  • Building 100, Suite 151
  • Orlando, FL 32817
  • United States
+1 (888) 000-0000

Fibronostics Timeline

Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Fibronostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 24-Aug-2020 $8M 000 Completed Generating Revenue
2. Corporate 31-May-2019 Completed Generating Revenue
1. Early Stage VC 01-Jan-2018 Completed Generating Revenue
To view Fibronostics’s complete valuation and funding history, request access »

Fibronostics Executive Team (6)

Name Title Board Seat Contact Info
Roni Amiel Chief Executive Officer
Thomas Fratacci Chief Financial Officer
Abhishek Aravind Chief Technology Officer
Missy Martin-Kemp Chief Commercial Officer
Ronald Quiambao Chief Medical Officer
You’re viewing 5 of 6 executive team members. Get the full list »

Fibronostics Board Members (3)

Name Representing Role Since
Ivan Jarry SPRIM Ventures Board Member 000 0000
Laurent Benissan SPRIM Ventures Board Member 000 0000
Michael Shleifer Ph.D SPRIM Ventures Board Member 000 0000
To view Fibronostics’s complete board members history, request access »

Fibronostics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fibronostics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
AT Capital Group PE/Buyout Minority 000 0000 000000 0 Venture Capital Minority 000 0000 000000 0
Ayala Healthcare Holdings Corporation Minority 000 0000 000000 0
Vigos Corporation Minority 000 0000 000000 0
SPRIM Ventures Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »